Coparion is a venture capital firm established in 2016 and headquartered in Cologne and Berlin, Germany. The firm specializes in providing financial support to early-stage companies, particularly in the technology sector, across Germany. With an active fund of EUR 275 million, Coparion aims to accelerate growth and momentum for its portfolio companies. The firm invests in collaboration with co-investors, typically committing up to EUR 15 million per company through multiple financing rounds ranging from EUR 0.5 to 8 million each. Coparion focuses on empowering entrepreneurs by offering expertise and insights while refraining from interfering in daily business operations. The team leverages its extensive experience in venture capital and company building to identify potential opportunities and navigate challenges effectively.
Protembis GmbH, founded in 2017 and based in Aachen, Germany, specializes in the manufacture of surgical equipment aimed at enhancing the safety of transcatheter aortic valve replacement (TAVR) procedures. The company has developed the ProtEmbo System, an intra-aortic filter device designed to mitigate the risk of cerebrovascular events during TAVR by deflecting embolic material away from the cerebral circulation. This innovation addresses a significant complication associated with TAVR, which has become a preferred treatment for patients with valvular heart disease, particularly as the procedure is increasingly performed on younger and lower-risk individuals. By minimizing the risk of brain injury, Protembis aims to improve patient outcomes and reduce healthcare costs related to surgical complications.
Tubulis
Series B in 2024
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly transformative antibody-drug conjugates (ADCs). The company focuses on creating innovative chemotherapeutic medications that are specifically tailored to combat cancer and chronic disorders. By integrating proprietary technologies with disease-specific biology, Tubulis aims to identify novel protein-drug combinations that enable clinicians to treat cancer patients while minimizing the risks and side effects typically associated with traditional chemotherapy.
Finoa
Venture Round in 2024
Finoa GmbH, founded in 2018 and based in Potsdam, Germany, provides regulated custody and asset-servicing solutions for digital assets. The company operates a digital asset platform that allows institutional investors and corporations to securely store and manage cryptographic tokens. Finoa's services include custody and staking, designed to accommodate users of varying familiarity with cryptocurrencies. The platform features advanced security measures such as multi-signature processing, biometric fingerprint access, and cryptographically secured private keys. As a qualified custodian supervised by the German Federal Financial Supervisory Authority, Finoa serves a diverse clientele, including venture capital firms, large corporations, and financial institutions, ensuring the safe and intuitive management of digital assets. The company is co-founded by Christopher May and Henrik Gebbing and is supported by several prominent financial investors.
Lanes & Planes
Series B in 2023
Lanes & Planes GmbH, founded in 2017 and based in Munich, Germany, specializes in providing comprehensive travel management solutions through a Software-as-a-Service (SaaS) platform. This platform digitally addresses all aspects of business travel, including search, booking, payment processing, and invoicing. The company's software offers a complete solution for organizations to manage their travel needs efficiently, featuring a mobile travel companion and ticket wallet that streamline the booking process and facilitate expense management. Through its application, Lanes & Planes enables companies to handle business travel bookings effectively, ensuring a seamless experience from start to finish.
Finoa
Funding Round in 2023
Finoa GmbH, founded in 2018 and based in Potsdam, Germany, provides regulated custody and asset-servicing solutions for digital assets. The company operates a digital asset platform that allows institutional investors and corporations to securely store and manage cryptographic tokens. Finoa's services include custody and staking, designed to accommodate users of varying familiarity with cryptocurrencies. The platform features advanced security measures such as multi-signature processing, biometric fingerprint access, and cryptographically secured private keys. As a qualified custodian supervised by the German Federal Financial Supervisory Authority, Finoa serves a diverse clientele, including venture capital firms, large corporations, and financial institutions, ensuring the safe and intuitive management of digital assets. The company is co-founded by Christopher May and Henrik Gebbing and is supported by several prominent financial investors.
CatalYm
Series C in 2022
CatalYm GmbH, founded in 2016 and based in Munich, Germany, is a biotechnology company focused on developing innovative immunotherapies for cancer patients. The company has identified GDF-15 as a key regulator of the immune system within the tumor microenvironment. By neutralizing GDF-15, CatalYm aims to enhance the immune response against solid tumors, potentially leading to meaningful clinical outcomes. Its CTL-002 program is designed to demonstrate clinical proof-of-concept across multiple solid tumor indications, offering the prospect of expanding treatment options for cancer patients. Through its approach, CatalYm seeks to transform the tumor microenvironment, making tumors more accessible to the immune system and improving both survival rates and quality of life for patients.
Holidu
Series E in 2022
Holidu GmbH is a technology-driven company based in Munich, Germany, that operates a platform for vacation rentals. Founded in 2014 by brothers Johannes and Michael Siebers, Holidu aims to simplify the search and booking process for holiday accommodations. Its search engine utilizes proprietary image recognition technology to compare prices and user reviews from numerous travel websites, including major platforms like Airbnb and Booking.com. This feature allows users to efficiently find and book their ideal vacation homes while potentially saving up to 55% on their bookings. Additionally, Holidu offers a mobile application to enhance the user experience, further facilitating the discovery of suitable rental properties based on individual preferences, budget, and travel dates.
Tubulis
Series B in 2022
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly transformative antibody-drug conjugates (ADCs). The company focuses on creating innovative chemotherapeutic medications that are specifically tailored to combat cancer and chronic disorders. By integrating proprietary technologies with disease-specific biology, Tubulis aims to identify novel protein-drug combinations that enable clinicians to treat cancer patients while minimizing the risks and side effects typically associated with traditional chemotherapy.
Lendis
Series A in 2022
Lendis GmbH, founded in 2018 and based in Berlin, Germany, specializes in providing a digital rental service for office infrastructure, including furniture and electronics. The company offers a range of products, such as desks, chairs, laptops, and smartphones, allowing clients to rent equipment on flexible terms. Users can choose to return items after three months or opt for long-term rentals. Lendis also provides a software-as-a-service (SaaS) solution, facilitating the management of employees' equipment in a hybrid working environment. This comprehensive approach has enabled Lendis to equip over 100,000 employees across more than 1,000 companies, helping businesses streamline device management and optimize their IT resources.
Cardior Pharmaceuticals
Series B in 2021
Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in the development of non-coding RNA-based therapeutics aimed at treating and preventing heart disease, a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a molecular master switch (microRNA) responsible for pathological changes in the heart resulting from stress or injury. By advancing innovative therapies, Cardior Pharmaceuticals aims to address significant health challenges associated with cardiovascular conditions.
shyftplan
Series A in 2021
shyftplan GmbH, based in Berlin, Germany, specializes in developing software solutions for the human resources sector. Founded in 2012, the company offers a comprehensive SaaS platform that facilitates employee management and communication. Its core functionality centers on shift scheduling, while also encompassing absence management, time tracking, working time accounts, HR management, and payroll services. The platform enables HR managers to create and manage shift plans, assigning employees to specific shifts based on their competencies. Additionally, shyftplan enhances workforce management by integrating employee intelligence and facilitating communication for non-desk workers, thus connecting them to their work environments and organizational frameworks.
Holidu
Series D in 2021
Holidu GmbH is a technology-driven company based in Munich, Germany, that operates a platform for vacation rentals. Founded in 2014 by brothers Johannes and Michael Siebers, Holidu aims to simplify the search and booking process for holiday accommodations. Its search engine utilizes proprietary image recognition technology to compare prices and user reviews from numerous travel websites, including major platforms like Airbnb and Booking.com. This feature allows users to efficiently find and book their ideal vacation homes while potentially saving up to 55% on their bookings. Additionally, Holidu offers a mobile application to enhance the user experience, further facilitating the discovery of suitable rental properties based on individual preferences, budget, and travel dates.
parcelLab
Series C in 2021
parcelLab GmbH is a Munich-based company that specializes in cloud-based solutions for online retailers, focusing on enhancing the post-purchase customer experience. Founded in 2014, the company offers a platform that enables real-time monitoring of parcel deliveries, helping retailers manage discrepancies and improve delivery management. By integrating carrier services and utilizing big data analysis, parcelLab provides proactive customer notifications and automates communication to enhance customer satisfaction and retention. Its technology is particularly beneficial for sectors such as fashion, consumer electronics, and furniture retail, allowing businesses to predict delivery delays and offer compensatory measures like coupons, ultimately aiming to boost revenue and reduce operational costs.
Finoa
Series A in 2021
Finoa GmbH, founded in 2018 and based in Potsdam, Germany, provides regulated custody and asset-servicing solutions for digital assets. The company operates a digital asset platform that allows institutional investors and corporations to securely store and manage cryptographic tokens. Finoa's services include custody and staking, designed to accommodate users of varying familiarity with cryptocurrencies. The platform features advanced security measures such as multi-signature processing, biometric fingerprint access, and cryptographically secured private keys. As a qualified custodian supervised by the German Federal Financial Supervisory Authority, Finoa serves a diverse clientele, including venture capital firms, large corporations, and financial institutions, ensuring the safe and intuitive management of digital assets. The company is co-founded by Christopher May and Henrik Gebbing and is supported by several prominent financial investors.
Clark
Series C in 2021
Clark is a Berlin-based insurance platform founded in June 2015 by Dr. Christopher Oster and Steffen Glomb. The company aims to simplify and enhance transparency in insurance coverage by leveraging technology and industry expertise. Through its digital platform, accessible via iOS and Android applications or a website, Clark assesses users' insurance statuses and provides tailored advice. It analyzes customers' insurance situations and identifies optimization opportunities by comparing tariffs from various insurance providers. This approach enables users to manage their insurance needs more effectively, ensuring they receive comprehensive coverage at competitive prices while promoting a customer-centric experience. Clark is supported by the FinTech incubator FinLeap and the Institute for Transparency.
CatalYm
Series B in 2020
CatalYm GmbH, founded in 2016 and based in Munich, Germany, is a biotechnology company focused on developing innovative immunotherapies for cancer patients. The company has identified GDF-15 as a key regulator of the immune system within the tumor microenvironment. By neutralizing GDF-15, CatalYm aims to enhance the immune response against solid tumors, potentially leading to meaningful clinical outcomes. Its CTL-002 program is designed to demonstrate clinical proof-of-concept across multiple solid tumor indications, offering the prospect of expanding treatment options for cancer patients. Through its approach, CatalYm seeks to transform the tumor microenvironment, making tumors more accessible to the immune system and improving both survival rates and quality of life for patients.
Qualifyze
Funding Round in 2020
Qualifyze GmbH operates an online B2B matching platform that connects buyers and sellers of raw materials, primarily serving the pharmaceutical and food industries. Founded in 2017 and based in Frankfurt am Main, Germany, the company provides access to a comprehensive database of audit reports from manufacturers, laboratories, and distributors. Its platform allows users to search for ingredients, review supplier audits for informed decision-making, and explore customized ingredient alternatives based on quality requirements. Additionally, Qualifyze supports pharmaceutical companies by offering insights into supplier compliance through a cloud-based system that captures and analyzes audit data. With a global network of over 200 local auditors and more than 1,000 clients, Qualifyze is recognized for its extensive database of supplier compliance information, helping healthcare partners monitor and optimize their quality and sustainability efforts effectively.
Tubulis
Series A in 2020
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly transformative antibody-drug conjugates (ADCs). The company focuses on creating innovative chemotherapeutic medications that are specifically tailored to combat cancer and chronic disorders. By integrating proprietary technologies with disease-specific biology, Tubulis aims to identify novel protein-drug combinations that enable clinicians to treat cancer patients while minimizing the risks and side effects typically associated with traditional chemotherapy.
Micropsi Industries
Series A in 2020
Micropsi Industries is building cognitive machines: Theyr’re providing high-end machine learning solutions for robotics and process control. micropsi industries MIRAI is a robot control system designed for complex assembly tasks. MIRAI-controlled robots perform movements that react to minute changes in the environment, as perceived by the robot with cameras or force sensors. MIRAI skills aren't programmed, but trained - through demonstration, correction, and repetition. This allows users to create skills without writing a single line of code or modelling the problem. The company was founded in 2014 by a group of experienced entrepreneurs, software engineers and scientists, most of them with cognitive science or machine learning backgrounds. micropsi industries is backed by Vito Ventures, coparion, and a group of experienced business angels from Munich and Berlin.
Lanes & Planes
Series A in 2020
Lanes & Planes GmbH, founded in 2017 and based in Munich, Germany, specializes in providing comprehensive travel management solutions through a Software-as-a-Service (SaaS) platform. This platform digitally addresses all aspects of business travel, including search, booking, payment processing, and invoicing. The company's software offers a complete solution for organizations to manage their travel needs efficiently, featuring a mobile travel companion and ticket wallet that streamline the booking process and facilitate expense management. Through its application, Lanes & Planes enables companies to handle business travel bookings effectively, ensuring a seamless experience from start to finish.
HepaRegenix
Series B in 2020
HepaRegeniX GmbH, founded in 2016 and based in Ulm, Germany, focuses on developing innovative drugs for acute and chronic liver diseases. The company's therapeutic approach is centered on a proprietary molecular target known as mitogen-activated protein kinase 4 (MKK4), identified as a crucial regulator of liver regeneration through research by Professor Lars Zender and his team at the University Hospital Tübingen. HepaRegeniX aims to create small-molecule inhibitors of MKK4 that can enhance the regenerative capacity of hepatocytes, even in severely diseased livers. This research has significant implications for treating various liver disorders, including nonalcoholic steatohepatitis.
Finoa
Seed Round in 2020
Finoa GmbH, founded in 2018 and based in Potsdam, Germany, provides regulated custody and asset-servicing solutions for digital assets. The company operates a digital asset platform that allows institutional investors and corporations to securely store and manage cryptographic tokens. Finoa's services include custody and staking, designed to accommodate users of varying familiarity with cryptocurrencies. The platform features advanced security measures such as multi-signature processing, biometric fingerprint access, and cryptographically secured private keys. As a qualified custodian supervised by the German Federal Financial Supervisory Authority, Finoa serves a diverse clientele, including venture capital firms, large corporations, and financial institutions, ensuring the safe and intuitive management of digital assets. The company is co-founded by Christopher May and Henrik Gebbing and is supported by several prominent financial investors.
parcelLab
Series B in 2019
parcelLab GmbH is a Munich-based company that specializes in cloud-based solutions for online retailers, focusing on enhancing the post-purchase customer experience. Founded in 2014, the company offers a platform that enables real-time monitoring of parcel deliveries, helping retailers manage discrepancies and improve delivery management. By integrating carrier services and utilizing big data analysis, parcelLab provides proactive customer notifications and automates communication to enhance customer satisfaction and retention. Its technology is particularly beneficial for sectors such as fashion, consumer electronics, and furniture retail, allowing businesses to predict delivery delays and offer compensatory measures like coupons, ultimately aiming to boost revenue and reduce operational costs.
Building Radar
Series A in 2019
Building Radar GmbH operates a data analysis platform that enables suppliers and service providers to identify building projects globally. Founded in 2014 and headquartered in Munich, Germany, the company offers real-time data and information on all phases of planning and construction. Utilizing advanced AI technology, Building Radar continuously scans the internet for construction project information, allowing customers to discover new and existing projects ahead of their competitors. This capability helps businesses in the construction supply chain, from concrete manufacturers to interior design providers, to engage with potential projects early and enhance their profit margins.
Tacalyx
Seed Round in 2019
Tacalyx GmbH is an oncology company based in Berlin, Germany, specializing in the discovery and development of Tumor-Associated Carbohydrate Antigens (TACAs) as innovative targets for cancer therapy. Originating as a spin-off from the Max-Planck-Institute of Colloids and Interfaces, Tacalyx leverages advanced carbohydrate synthesis technology to produce highly pure TACA structures. These structures are essential for generating and identifying antibodies aimed at developing new therapeutics. TACAs are characterized by their specific expression in tumors, which arises from abnormal glycosylation and is associated with promoting metastasis, angiogenesis, and immune system suppression. By combining sophisticated synthesis capabilities with comprehensive analysis and screening, Tacalyx aims to create novel immunotherapies that effectively stimulate anti-cancer responses.
Holidu
Series C in 2019
Holidu GmbH is a technology-driven company based in Munich, Germany, that operates a platform for vacation rentals. Founded in 2014 by brothers Johannes and Michael Siebers, Holidu aims to simplify the search and booking process for holiday accommodations. Its search engine utilizes proprietary image recognition technology to compare prices and user reviews from numerous travel websites, including major platforms like Airbnb and Booking.com. This feature allows users to efficiently find and book their ideal vacation homes while potentially saving up to 55% on their bookings. Additionally, Holidu offers a mobile application to enhance the user experience, further facilitating the discovery of suitable rental properties based on individual preferences, budget, and travel dates.
Vehiculum
Series A in 2019
Vehiculum is an online platform based in Berlin, Germany, that specializes in car leasing services. Founded in July 2015 by Lukas Steinhilber, Melchior Bauer, and Guy Moller, the company aims to digitize the leasing process by providing users with an independent and transparent overview of various leasing offers. It features a wide selection of car models, allowing users to compare real-time prices easily. Additionally, Vehiculum facilitates the creation of leasing requests, streamlining the process for clients looking to lease vehicles efficiently. The platform focuses on enhancing transparency and simplifying contract management for its users.
Vimcar
Series B in 2018
Vimcar GmbH, founded in 2013 and based in Berlin, Germany, specializes in digital fleet management solutions aimed at small and medium-sized businesses. The company has developed a digital car logbook that utilizes an onboard diagnostic (OBD) plug, connecting vehicles to the cloud to record trip data. This innovative platform combines live vehicle data with cloud-based applications, providing real-time insights that help reduce operational costs and ensure legal compliance for fleet managers. Vimcar's services are designed to seamlessly integrate commercial vehicles into digital ecosystems, and it has successfully equipped over 110,000 vehicles in German-speaking countries. In early 2020, the company announced its expansion into the United Kingdom.
Wirelane
Series A in 2018
WIRELANE GmbH, based in Saarbrücken, Germany, specializes in designing and developing electric vehicle charging stations. Established in 2016, the company focuses on sustainable mobility by offering innovative solutions for the construction, operation, and marketing of charging infrastructure. Wirelane provides a comprehensive range of services, including cutting-edge charging technology, a digital management and billing platform, and extensive installation and maintenance services. Additionally, the company enables clients to manage charging processes effectively, facilitating the implementation of large-scale charging infrastructure projects for electric vehicles.
Micropsi Industries
Series A in 2018
Micropsi Industries is building cognitive machines: Theyr’re providing high-end machine learning solutions for robotics and process control. micropsi industries MIRAI is a robot control system designed for complex assembly tasks. MIRAI-controlled robots perform movements that react to minute changes in the environment, as perceived by the robot with cameras or force sensors. MIRAI skills aren't programmed, but trained - through demonstration, correction, and repetition. This allows users to create skills without writing a single line of code or modelling the problem. The company was founded in 2014 by a group of experienced entrepreneurs, software engineers and scientists, most of them with cognitive science or machine learning backgrounds. micropsi industries is backed by Vito Ventures, coparion, and a group of experienced business angels from Munich and Berlin.
Protembis
Series A in 2018
Protembis GmbH, founded in 2017 and based in Aachen, Germany, specializes in the manufacture of surgical equipment aimed at enhancing the safety of transcatheter aortic valve replacement (TAVR) procedures. The company has developed the ProtEmbo System, an intra-aortic filter device designed to mitigate the risk of cerebrovascular events during TAVR by deflecting embolic material away from the cerebral circulation. This innovation addresses a significant complication associated with TAVR, which has become a preferred treatment for patients with valvular heart disease, particularly as the procedure is increasingly performed on younger and lower-risk individuals. By minimizing the risk of brain injury, Protembis aims to improve patient outcomes and reduce healthcare costs related to surgical complications.
Fractal
Seed Round in 2018
Fractal is an identity verification platform, ranging from human uniqueness for sybil-resistance to KYC/AML for regulatory compliance. Fractal provides decentralized identity solutions for Web3 users and chains ensuring trustless systems and empowering users to exchange their data in a privacy-preserving way It was founded in 2017 and is headquartered in Berlin, Germany.
virtualQ
Series A in 2018
virtualQ GmbH, founded in 2014 and based in Berlin, Germany, specializes in providing innovative call waiting services for call centers and hotlines. The company's solutions include a Call-In and Call-Back system that effectively eliminates wait times and balances high-quality service with cost efficiency. In peak situations, virtualQ holds the caller's place in line, notifying them when it is their turn to connect with the next available agent. This service is accessible through various platforms, including phone calls, web interfaces, and mobile applications. By utilizing virtualQ's technology, clients can significantly reduce service center call times while enhancing customer experience and satisfaction.
Fasciotens
Seed Round in 2018
Fasciotens GmbH is a medical technology company based in Essen, Germany, founded in 2016. The company specializes in developing innovative devices for open abdomen therapy, which is crucial in treating severe infections, postoperative complications, and injuries that necessitate leaving the abdomen open. This therapy can be life-saving, particularly in cases such as abdominal compartment syndrome. Fasciotens' approach involves a unique method that maintains tension in the abdominal wall while increasing intra-abdominal volume. This technique combines the principles of mesh-mediated traction with those of an external fixator, ultimately enhancing the likelihood of successful outcomes for critically ill patients. Through its advanced solutions, Fasciotens aims to improve medical care in challenging surgical situations involving the open abdomen.
Clark
Series B in 2018
Clark is a Berlin-based insurance platform founded in June 2015 by Dr. Christopher Oster and Steffen Glomb. The company aims to simplify and enhance transparency in insurance coverage by leveraging technology and industry expertise. Through its digital platform, accessible via iOS and Android applications or a website, Clark assesses users' insurance statuses and provides tailored advice. It analyzes customers' insurance situations and identifies optimization opportunities by comparing tariffs from various insurance providers. This approach enables users to manage their insurance needs more effectively, ensuring they receive comprehensive coverage at competitive prices while promoting a customer-centric experience. Clark is supported by the FinTech incubator FinLeap and the Institute for Transparency.
parcelLab
Series A in 2018
parcelLab GmbH is a Munich-based company that specializes in cloud-based solutions for online retailers, focusing on enhancing the post-purchase customer experience. Founded in 2014, the company offers a platform that enables real-time monitoring of parcel deliveries, helping retailers manage discrepancies and improve delivery management. By integrating carrier services and utilizing big data analysis, parcelLab provides proactive customer notifications and automates communication to enhance customer satisfaction and retention. Its technology is particularly beneficial for sectors such as fashion, consumer electronics, and furniture retail, allowing businesses to predict delivery delays and offer compensatory measures like coupons, ultimately aiming to boost revenue and reduce operational costs.
Lofelt
Series A in 2017
Lofelt is developing cutting-edge haptic technology. Their aim is to provide the most remarkable haptic experiences on the market – spearheading the adoption of high-definition haptics in mobile, AR/VR, headset and gaming industries. Their first consumer product was the Basslet - a wearable watch-sized subwoofer. They are currently working with world-renowned brands to improve the user experience in some of the most recognized consumer products and they recently partnered with Razer to launch the Razer Nari Ultimate Wireless Headset. As a deep tech company in the heart of Berlin, they stay true to German engineering heritage while growing our business globally. They are an efficient, meticulous and fast-moving company driven by a dynamic team. Their hardware mechanics, electrical engineers, software developers, product designers and business professionals come together to create truly remarkable haptic experiences.
Vehiculum
Seed Round in 2017
Vehiculum is an online platform based in Berlin, Germany, that specializes in car leasing services. Founded in July 2015 by Lukas Steinhilber, Melchior Bauer, and Guy Moller, the company aims to digitize the leasing process by providing users with an independent and transparent overview of various leasing offers. It features a wide selection of car models, allowing users to compare real-time prices easily. Additionally, Vehiculum facilitates the creation of leasing requests, streamlining the process for clients looking to lease vehicles efficiently. The platform focuses on enhancing transparency and simplifying contract management for its users.
shyftplan
Series A in 2017
shyftplan GmbH, based in Berlin, Germany, specializes in developing software solutions for the human resources sector. Founded in 2012, the company offers a comprehensive SaaS platform that facilitates employee management and communication. Its core functionality centers on shift scheduling, while also encompassing absence management, time tracking, working time accounts, HR management, and payroll services. The platform enables HR managers to create and manage shift plans, assigning employees to specific shifts based on their competencies. Additionally, shyftplan enhances workforce management by integrating employee intelligence and facilitating communication for non-desk workers, thus connecting them to their work environments and organizational frameworks.
FastBill
Series A in 2017
FastBill GmbH, based in Essen, Germany, specializes in web-based finance management solutions tailored for small businesses, freelancers, and e-commerce users. The company offers a comprehensive suite of tools that enables users to create and send estimates, invoices, and credit notes online. Additionally, FastBill's platform facilitates digital document management for services and products, project organization, expense tracking, and financial reporting. Its features also include time tracking and client management options. By integrating accounting and banking functions within a user-friendly interface, FastBill streamlines bookkeeping processes, allowing users to automate data transmission and focus on their core business activities.
CEPRES
Series A in 2017
CEPRES GmbH is a Munich-based company specializing in investment decision support tools tailored for the private capital market. Founded in 2001, it provides a platform that connects investment professionals, including institutional investors, fund managers, and advisors, facilitating interactions that enhance decision-making processes. The platform offers a range of services, such as benchmarking users' track records, optimizing asset allocations, and conducting due diligence. With access to extensive proprietary deal data and cash flows from a vast ecosystem, CEPRES enables clients to leverage real-time and predictive analytics for improved investment outcomes. This digital transformation solution is designed to streamline operations and accelerate decision-making in the private equity landscape.
Green City Solutions
Seed Round in 2017
Green City Solutions GmbH, founded in 2014 and based in Berlin, Germany, focuses on addressing air pollution through innovative waste management solutions. The company has developed the “CityTree,” a product that features a specially designed, vertically installed moss culture combined with Internet-of-Things (IoT) technology. This unique system targets particulate matter, nitrogen dioxide, and ozone, improving air quality by utilizing specific plants that purify the air while also providing cooling and humidification. The CityTree is equipped with sensors that gather environmental and climatic data, allowing for the regulation and optimization of plant performance. Additionally, the collected data contributes to enhancing the understanding of environmental conditions in urban areas.
HepaRegenix
Series A in 2016
HepaRegeniX GmbH, founded in 2016 and based in Ulm, Germany, focuses on developing innovative drugs for acute and chronic liver diseases. The company's therapeutic approach is centered on a proprietary molecular target known as mitogen-activated protein kinase 4 (MKK4), identified as a crucial regulator of liver regeneration through research by Professor Lars Zender and his team at the University Hospital Tübingen. HepaRegeniX aims to create small-molecule inhibitors of MKK4 that can enhance the regenerative capacity of hepatocytes, even in severely diseased livers. This research has significant implications for treating various liver disorders, including nonalcoholic steatohepatitis.
Clark
Series A in 2016
Clark is a Berlin-based insurance platform founded in June 2015 by Dr. Christopher Oster and Steffen Glomb. The company aims to simplify and enhance transparency in insurance coverage by leveraging technology and industry expertise. Through its digital platform, accessible via iOS and Android applications or a website, Clark assesses users' insurance statuses and provides tailored advice. It analyzes customers' insurance situations and identifies optimization opportunities by comparing tariffs from various insurance providers. This approach enables users to manage their insurance needs more effectively, ensuring they receive comprehensive coverage at competitive prices while promoting a customer-centric experience. Clark is supported by the FinTech incubator FinLeap and the Institute for Transparency.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.